ClinicalTrials.gg
Enrolling by invitationNCT02402426BHRUpdated Jan 13, 2026

Brain Health Registry: An Online Registry to Identify and Assess Subjects for Brain Research

An observational study in Healthy and Neurodegenerative Disease, sponsored by University of California, San Francisco. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-13.

Sponsored by University of California, San Francisco · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200,000
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 176 studies in Neurodegenerative Diseases with a site in United States — 45 open to participants now, 58 under way, 4 of them phase 3. Neurodegenerative Diseases · United States.

Planned enrollment
4th of 54
200,000 · median 85
Started
2013
with 5 others
Observational
54 of 176
18 open now
Primary completion
2030-09
later than 47 of 56 live
Registered
40th of 176
by date

Among the 176 studies in Neurodegenerative Diseases with a site in United States, this one is the 4th largest by planned enrollment of the 54 observational ones that give a count, is one of 6 that started in 2013, is one of 54 observational ones, reaches primary completion later than 47 of the 56 other live ones, and was the 40th registered.

Neurodegenerative Diseases

436 studies on the registry are indexed under Neurodegenerative Diseases; 143 are open to participants now.

Browse Neurodegenerative Diseases studies →

Open to participants now

45 of the 176 studies in Neurodegenerative Diseases with a site in United States are open now. Recruiting first, the newest first:

40 more — sign in →

All 45 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 101 Neurodegenerative Diseases studies recruiting now, 52 (51%) set no upper age limit and 11 (11%) stop at 75 or younger; 20 take children under 18; 49 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 176 studies in Neurodegenerative Diseases with a site in United States, or all of them as a file.
02

Study summary

The overall goal of this project is to identify, assess and longitudinally monitor subjects who are interested in participating in brain research. Participants will enroll through the website, BrainHealthRegistry.org, and provide informed consent prior to any study activities. The website will collect a variety of information, including participants' overall health, memory complaints, family history of dementia and Alzheimer's disease (AD), mood status, sleep, diet, and exercise-all through self-reported online questionnaires. Participants will also be ask to take online cognitive tests, and to return to the website at regular intervals, to complete follow-up questionnaires and neuropsychological assessments. Everyone over the age of 18 is welcome to participate. To join the Brain Health Registry, please visit www.BrainHealthRegistry.org.

Read the detailed description

Through advertisement and community outreach, potential participants will be directed to the website, BrainHealthRegistry.org. The overall goal of this project is to identify, assess and longitudinally monitor subjects who are interested in participating in brain research. Participants will enroll through the website, BrainHealthRegistry.org, and provide informed consent prior to any study activities.

The website will include:

  1. Information about the Brain Health Registry (who is eligible to participate, the goals of the project and other relevant information about investigators and sponsors involved in the Initiative)
  2. Frequently Asked Questions (FAQs) such as "How will my information be used?", "How will patient information be safeguarded?", "What information will be requested?", "How much time will be required for registration and testing?" will be addressed for participants.
  3. General information about Alzheimer's disease and other neurodegenerative diseases discussed in lay terms Links to sites that may be of interest to participants
  4. Login to our secure Registry website

The Registry will be a large, online database of volunteers who are interested in participating in neuroscience research. While anyone over the age of 18 is welcome to join the Registry, the intent is to concentrate all efforts on enrolling participants age 55 years and older. It will consist of online tools and databases, which are HIPAA-compliant and secure.

  1. Participants will access the Registry by going to the BHR website, BrainHealthRegistry.org
  2. Participants will provide their email address and create an account and user name with the Registry
  3. The Registry will send an automatic email to the participant to verify their email address
  4. Participants will read the online Information Sheet and will be asked to provide their consent by clicking either "I consent" or "I decline." Participants who decline to participate in the Registry will be automatically directed out of the Registry website
  5. Participants who give their consent will be permitted to continue through the registration process, which includes completing a battery of questionnaires designed to obtain a general understanding of participants health, medical history wellbeing
  6. In addition to questionnaires, participants will be able to complete online cognitive assessments.
  7. Participants will given the option to elect a Caregiver and/or Study Partner (CASP) to enrich their study profile.
  8. Participants may be referred to other research studies and/or clinical trials
03

Conditions studied

  • Healthy
  • Neurodegenerative Disease

Keywords

  • Brain Health
  • Brain Research
  • Alzheimer's Disease
  • Neurodegenerative Disease
  • Parkinson's Disease
  • Dementia
  • Stroke
  • PTSD
  • Multiple Sclerosis
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The Registry is a large, online database of volunteers who would like to participate in clinical trials and research. Anyone over the age of 18 is welcome to join the Registry, and the intent is to concentrate all efforts on enrolling participants age 55 years and older.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Anyone over the age of 18 is welcome to join the Registry

Exclusion criteria

Exclusion Criteria:

  • N/A
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200,000 participants (estimated)
Target follow-up
10 Years
Patient registry
Yes
06

What researchers measure

Primary outcomes

  1. Alzheimer's Disease

    The overall goal of The Brain Health Registry is to facilitate and accelerate treatments for diseases which affect the brain.

    Time frame: 10 years

Secondary outcomes

  1. Neurodegenerative Diseases

    The main goal of this project is to promote healthy brain aging through the prevention of Alzheimer's disease and other neurodegenerative diseases such as Parkinson's disease, depression, stroke and other conditions that affect brain function in older adults. Our broader goal is to develop an innovative model for subject recruitment and clinical trials of treatments for brain disorders across the age spectrum.

    Time frame: 10 years

07

Study locations

1 site
  • BrainHealthRegistry.org
    San Francisco, California 94143, United States
08

References and documents

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Sep 2013, a primary completion of Sep 2030 and a completion of Sep 2030. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 1, 2013
First posted
Mar 30, 2015
Start
Sep 2013
Primary completionEst.
Sep 2030
CompletionEst.
Sep 2030
Last update
Jan 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02402426
Responsible party
Sponsor
First posted
Mar 30, 2015
Start date
Sep 2013
Primary completion
Sep 2030 (estimated)
Completion
Sep 2030 (estimated)
Last update
Jan 13, 2026

Study contacts

Michael Weiner, MD
principal investigator · University of California, San Francisco

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion